Prosecution Insights
Last updated: April 19, 2026
Application No. 17/386,594

Combination of Soybean Whole Genome SNP Loci, Gene Chip and Application Thereof

Non-Final OA §101§102§112
Filed
Jul 28, 2021
Examiner
ZHANG, KAIJIANG
Art Unit
1684
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Northeast Institute of Geography and Agroecology, Chinese Academy of Sciences
OA Round
1 (Non-Final)
76%
Grant Probability
Favorable
1-2
OA Rounds
2y 11m
To Grant
99%
With Interview

Examiner Intelligence

Grants 76% — above average
76%
Career Allow Rate
518 granted / 678 resolved
+16.4% vs TC avg
Strong +36% interview lift
Without
With
+35.5%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
28 currently pending
Career history
706
Total Applications
across all art units

Statute-Specific Performance

§101
6.3%
-33.7% vs TC avg
§103
26.5%
-13.5% vs TC avg
§102
24.5%
-15.5% vs TC avg
§112
26.6%
-13.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 678 resolved cases

Office Action

§101 §102 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status 1. The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions 2. Applicant’s election of Group II (claims 2-4) in the reply filed on 11/25/2025 is acknowledged. Because applicant did not distinctly and specifically point out the supposed errors in the restriction requirement, the election has been treated as an election without traverse (MPEP § 818.01(a)). 3. Claims 1-10 are pending in the application. Claims 1 and 5-10 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Claims 2-4 are currently under examination. Specification 4. The disclosure is objected to because it contains an embedded hyperlink and/or other form of browser-executable code (see page 2 line 22 and page 201 line 2 of the specification as filed; or see paragraphs [0011] and [0029] of the pre-grant publication). Applicant is required to delete the embedded hyperlink and/or other form of browser-executable code; references to websites should be limited to the top-level domain name without any prefix such as http:// or other browser-executable code. See MPEP § 608.01. 5. The lengthy specification has not been checked to the extent necessary to determine the presence of all possible minor errors. Applicant’s cooperation is requested in correcting any errors of which applicant may become aware in the specification. Claim Rejections - 35 USC § 112 6. The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. 7. Claim 2 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 2 is drawn to “[a] set of probes for detecting the combination of soybean whole genome SNP loci according to claim 1” (emphasis provided). Since there are different approaches for detecting SNPs, such as (1) sequencing-based approach where the probes (e.g., adapters and/or primers) used are universally applicable to all sorts of target genomic DNA (see the reference cited below in the rejection under 35 USC 102) and (2) hybridization-based genotyping approach where the hybridization probes have sequences specific to the SNP loci to be detected, probes for detecting SNPs can mean vastly different things. Accordingly, claim 2 is indefinite for failing to define the metes and bounds of the recited “probes” because there are multiple and different ways (e.g., (1) probes, such as adapters and/or primers, used in sequencing-based approach where such probes are universally applicable to all sorts of target genomic DNA and are not specific to the SNPs to be detected; or (2) hybridization probes used in hybridization-based genotyping approach where such probes have sequences specific to the SNP loci to be detected) to interpret the currently claimed set of “probes” (see MPEP 2173.02.I: “…For example, if the language of a claim, given its broadest reasonable interpretation, is such that a person of ordinary skill in the relevant art would read it with more than one reasonable interpretation, then a rejection under 35 U.S.C. 112(b) or pre-AIA 35 U.S.C. 112, second paragraph is appropriate.”). Claim Rejections - 35 USC § 101 8. 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. 9. Claims 2-4 are rejected under 35 U.S.C. 101 because the claimed invention is directed to a judicial exception (i.e., product(s) of nature) without significantly more. Regarding claim 2 Claim 2 is drawn to a set of probes for detecting the combination of soybean whole genome SNP loci according to claim 1. If the probes are interpreted as hybridization probes used in hybridization-based genotyping approach (i.e., approach (2) as discussed in the 112(b) rejection above), such probes would have the same nucleotide sequences as the corresponding naturally occurring soybean genomic DNA sequences and thus the claimed set of probes would be directed to product(s) of nature which is a judicial exception. The judicial exception (i.e., product(s) of nature) is not integrated into a practical application because the claimed set of probes can be just naturally occurring soybean genomic DNA fragments. The claim does not include additional elements that are sufficient to amount to significantly more than the judicial exception because there is no additional structural element recited in the claim. Regarding claims 3-4 Claims 3-4 are directed to a gene chip for detecting the combination of soybean whole genome SNP loci according to claim 1, wherein the gene chip is a liquid-phase chip containing a set of nucleotide probes for detecting the SNP loci according to claim 1, and wherein a solution system of the liquid-phase chip is nuclease-free water. As currently presented, the claimed liquid-phase gene chip appears to be just a set of nucleotide probes in an aqueous solution. Assuming these nucleotide probes are used in hybridization-based genotyping approach, such nucleotide probes would have the same nucleotide sequences as the corresponding naturally occurring soybean genomic DNA sequences and thus the claims would be directed to product(s) of nature which is a judicial exception. The judicial exception (i.e., product(s) of nature) is not integrated into a practical application because the claimed liquid-phase chip seems to comprise only a set of nucleotide probes in an aqueous solution, where the nucleotide probes are naturally occurring soybean genomic DNA fragments and the solvent (i.e., water) is also a naturally occurring material that exists in soybean cells. Thus, the claims do not include additional elements that are sufficient to amount to significantly more than the judicial exception. Claim Rejections - 35 USC § 102 10. In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. 11. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention. 12. Claim 2 is rejected under 35 U.S.C. 102(a)(1) as being anticipated by Elshire et al. (PLoS ONE 2011, 6(5):e19379). Elshire et al. disclose a set of probes (e.g., adapters, PCR primers, and/or sequencing primers. See the whole document, particularly Figure 1) that can be universally used in a Genotyping-by-Sequencing (GBS) based approach for detecting all sorts of genomic SNP loci. Conclusion 13. No claim is allowed. Any inquiry concerning this communication or earlier communications from the examiner should be directed to KAIJIANG ZHANG whose telephone number is (571)272-5207. The examiner can normally be reached Monday - Friday, 8:30 am - 5 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Heather Calamita can be reached on 571-272-2876. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /KAIJIANG ZHANG/Primary Examiner, Art Unit 1684
Read full office action

Prosecution Timeline

Jul 28, 2021
Application Filed
Jan 25, 2022
Response after Non-Final Action
Jan 28, 2026
Non-Final Rejection — §101, §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12600961
METHODS AND SYSTEMS FOR DROPLET-BASED SINGLE CELL BARCODING
2y 5m to grant Granted Apr 14, 2026
Patent 12595500
HIGH EFFICIENCY, SMALL VOLUME NUCLEIC ACID SYNTHESIS
2y 5m to grant Granted Apr 07, 2026
Patent 12584169
COMPOSITIONS AND METHODS FOR IMPROVING SAMPLE IDENTIFICATION IN INDEXED NUCLEIC ACID LIBRARIES
2y 5m to grant Granted Mar 24, 2026
Patent 12584170
METHOD OF NANOPORE SEQUENCING OF CONCATENATED NUCLEIC ACIDS
2y 5m to grant Granted Mar 24, 2026
Patent 12571036
METHODS, DEVICES, AND SYSTEMS FOR ANALYTE DETECTION AND ANALYSIS
2y 5m to grant Granted Mar 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
76%
Grant Probability
99%
With Interview (+35.5%)
2y 11m
Median Time to Grant
Low
PTA Risk
Based on 678 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month